Fineline Cube

Follow:
14398 Articles
Eisai and Biogen Complete BLA Submission for Alzheimer’s Drug Leqembi to FDA
CompanyDrug

Eisai and Biogen Complete BLA Submission for Alzheimer’s Drug Leqembi to FDA

Jenscare Scientific's LuX-Valve Plus Shows Positive One-Year Results in TRAVEL II Study
CompanyMedical Device

Jenscare Scientific’s LuX-Valve Plus Shows Positive One-Year Results in TRAVEL II Study

Biogen Reports Q3 2024 Sales Dip, Raises Full-Year Guidance
Company

Biogen Reports Q3 2024 Sales Dip, Raises Full-Year Guidance

Tasly Pharmaceuticals Gets FDA Approval for Acute Ischemic Stroke Cell Therapy Clinical Study
CompanyDrug

Tasly Pharmaceuticals Gets FDA Approval for Acute Ischemic Stroke Cell Therapy Clinical Study

HutchMed to Receive $20 Million Milestone Payment from Takeda for Fruzaqla Sales
CompanyDeals

HutchMed to Receive $20 Million Milestone Payment from Takeda for Fruzaqla Sales

Zhejiang Huahai Pharmaceutical Gets New Zealand Approval for Asthma Bispecific Antibody Trial
CompanyDrug

Zhejiang Huahai Pharmaceutical Gets New Zealand Approval for Asthma Bispecific Antibody Trial

Youcare Pharmaceutical Group Gets NMPA Approval for YKYY015 Phase I Study
CompanyDrug

Youcare Pharmaceutical Group Gets NMPA Approval for YKYY015 Phase I Study

Innovent Biologics Reports Q3 2024 Sales Exceeding RMB 2.3 Billion, Up 40% YOY
CompanyDrug

Innovent Biologics Reports Q3 2024 Sales Exceeding RMB 2.3 Billion, Up 40% YOY

CStone Pharmaceuticals' Sugemalimab Wins UK Approval for NSCLC Treatment
CompanyDrug

CStone Pharmaceuticals’ Sugemalimab Wins UK Approval for NSCLC Treatment

Dizal Pharmaceutical's Q3 2024 Revenues Soar 236% YOY on Strong Product Sales
Company

Dizal Pharmaceutical’s Q3 2024 Revenues Soar 236% YOY on Strong Product Sales

Amgen Reports Q3 2024 Revenues of USD 8.5 Billion, Marking a 23% YOY Increase
Company

Amgen Reports Q3 2024 Revenues of USD 8.5 Billion, Marking a 23% YOY Increase

HOB Biotech Group and Sino Biopharmaceutical Ltd Form Strategic Partnership in Allergy Treatments
CompanyDeals

HOB Biotech Group and Sino Biopharmaceutical Ltd Form Strategic Partnership in Allergy Treatments